vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and VARONIS SYSTEMS INC (VRNS). Click either name above to swap in a different company.

VARONIS SYSTEMS INC is the larger business by last-quarter revenue ($173.1M vs $121.8M, roughly 1.4× Core Laboratories Inc.). On growth, VARONIS SYSTEMS INC posted the faster year-over-year revenue change (26.9% vs -1.4%). VARONIS SYSTEMS INC produced more free cash flow last quarter ($49.0M vs $517.0K). Over the past eight quarters, VARONIS SYSTEMS INC's revenue compounded faster (15.2% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

Varonis Systems, Inc. is a software company based in Miami, Florida with R&D offices in Herzliya, Israel. The company’s Data Security Platform analyzes data and data activity using the insights to identify data exposure risks stemming from access permissions and software-as-a-service (SaaS) app configurations, triggering automated remediation capabilities in response.

CLB vs VRNS — Head-to-Head

Bigger by revenue
VRNS
VRNS
1.4× larger
VRNS
$173.1M
$121.8M
CLB
Growing faster (revenue YoY)
VRNS
VRNS
+28.4% gap
VRNS
26.9%
-1.4%
CLB
More free cash flow
VRNS
VRNS
$48.5M more FCF
VRNS
$49.0M
$517.0K
CLB
Faster 2-yr revenue CAGR
VRNS
VRNS
Annualised
VRNS
15.2%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
CLB
CLB
VRNS
VRNS
Revenue
$121.8M
$173.1M
Net Profit
$5.1M
Gross Margin
76.0%
Operating Margin
1.5%
-1.7%
Net Margin
4.2%
Revenue YoY
-1.4%
26.9%
Net Profit YoY
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
VRNS
VRNS
Q1 26
$121.8M
$173.1M
Q4 25
$138.3M
$173.4M
Q3 25
$134.5M
$161.6M
Q2 25
$130.2M
$152.2M
Q1 25
$123.6M
$136.4M
Q4 24
$129.2M
$158.5M
Q3 24
$134.4M
$148.1M
Q2 24
$130.6M
$130.3M
Net Profit
CLB
CLB
VRNS
VRNS
Q1 26
$5.1M
Q4 25
$4.9M
$-27.8M
Q3 25
$14.2M
$-29.9M
Q2 25
$10.6M
$-35.8M
Q1 25
$-154.0K
$-35.8M
Q4 24
$7.4M
$-13.0M
Q3 24
$11.7M
$-18.3M
Q2 24
$9.0M
$-23.9M
Gross Margin
CLB
CLB
VRNS
VRNS
Q1 26
76.0%
Q4 25
20.8%
78.9%
Q3 25
22.0%
78.2%
Q2 25
20.3%
79.5%
Q1 25
19.5%
78.7%
Q4 24
17.8%
83.6%
Q3 24
20.5%
83.8%
Q2 24
21.2%
82.8%
Operating Margin
CLB
CLB
VRNS
VRNS
Q1 26
1.5%
-1.7%
Q4 25
11.5%
-17.5%
Q3 25
15.6%
-22.2%
Q2 25
11.7%
-24.0%
Q1 25
3.6%
-32.1%
Q4 24
11.0%
-11.1%
Q3 24
14.7%
-16.0%
Q2 24
12.3%
-22.1%
Net Margin
CLB
CLB
VRNS
VRNS
Q1 26
4.2%
Q4 25
3.6%
-16.0%
Q3 25
10.6%
-18.5%
Q2 25
8.2%
-23.5%
Q1 25
-0.1%
-26.2%
Q4 24
5.7%
-8.2%
Q3 24
8.7%
-12.4%
Q2 24
6.9%
-18.4%
EPS (diluted)
CLB
CLB
VRNS
VRNS
Q1 26
$0.11
Q4 25
$0.11
$-0.23
Q3 25
$0.30
$-0.26
Q2 25
$0.22
$-0.32
Q1 25
$0.00
$-0.32
Q4 24
$0.15
$-0.12
Q3 24
$0.25
$-0.16
Q2 24
$0.19
$-0.21

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
VRNS
VRNS
Cash + ST InvestmentsLiquidity on hand
$22.8M
$179.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$275.1M
$453.5M
Total Assets
$587.7M
$1.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
VRNS
VRNS
Q1 26
$22.8M
$179.3M
Q4 25
$22.7M
$883.7M
Q3 25
$25.6M
$671.3M
Q2 25
$31.2M
$770.9M
Q1 25
$22.1M
$567.6M
Q4 24
$19.2M
$529.0M
Q3 24
$21.5M
$844.8M
Q2 24
$17.7M
$582.5M
Total Debt
CLB
CLB
VRNS
VRNS
Q1 26
Q4 25
$110.3M
Q3 25
$114.1M
Q2 25
$124.6M
Q1 25
$124.4M
Q4 24
$126.1M
Q3 24
$139.9M
Q2 24
$147.6M
Stockholders' Equity
CLB
CLB
VRNS
VRNS
Q1 26
$275.1M
$453.5M
Q4 25
$266.0M
$598.7M
Q3 25
$271.3M
$604.8M
Q2 25
$261.3M
$341.5M
Q1 25
$253.4M
$367.7M
Q4 24
$246.6M
$455.7M
Q3 24
$250.7M
$428.6M
Q2 24
$240.3M
$458.6M
Total Assets
CLB
CLB
VRNS
VRNS
Q1 26
$587.7M
$1.6B
Q4 25
$584.0M
$1.8B
Q3 25
$591.4M
$1.7B
Q2 25
$602.1M
$1.6B
Q1 25
$591.5M
$1.6B
Q4 24
$585.1M
$1.7B
Q3 24
$600.5M
$1.5B
Q2 24
$597.8M
$1.1B
Debt / Equity
CLB
CLB
VRNS
VRNS
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
VRNS
VRNS
Operating Cash FlowLast quarter
$4.0M
$55.0M
Free Cash FlowOCF − Capex
$517.0K
$49.0M
FCF MarginFCF / Revenue
0.4%
28.3%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.77×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$118.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
VRNS
VRNS
Q1 26
$4.0M
$55.0M
Q4 25
$7.9M
$24.7M
Q3 25
$8.5M
$33.4M
Q2 25
$13.9M
$21.3M
Q1 25
$6.7M
$68.0M
Q4 24
$20.6M
$24.3M
Q3 24
$13.1M
$22.5M
Q2 24
$17.1M
$11.7M
Free Cash Flow
CLB
CLB
VRNS
VRNS
Q1 26
$517.0K
$49.0M
Q4 25
$5.0M
$20.7M
Q3 25
$6.5M
$30.4M
Q2 25
$10.4M
$18.0M
Q1 25
$3.9M
$65.7M
Q4 24
$17.4M
$19.9M
Q3 24
$10.4M
$21.3M
Q2 24
$14.3M
$10.9M
FCF Margin
CLB
CLB
VRNS
VRNS
Q1 26
0.4%
28.3%
Q4 25
3.6%
12.0%
Q3 25
4.8%
18.8%
Q2 25
8.0%
11.8%
Q1 25
3.1%
48.1%
Q4 24
13.4%
12.6%
Q3 24
7.7%
14.4%
Q2 24
10.9%
8.4%
Capex Intensity
CLB
CLB
VRNS
VRNS
Q1 26
Q4 25
2.1%
2.3%
Q3 25
1.5%
1.8%
Q2 25
2.7%
2.2%
Q1 25
2.3%
1.7%
Q4 24
2.5%
2.7%
Q3 24
2.0%
0.8%
Q2 24
2.2%
0.6%
Cash Conversion
CLB
CLB
VRNS
VRNS
Q1 26
0.77×
Q4 25
1.61×
Q3 25
0.60×
Q2 25
1.31×
Q1 25
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

VRNS
VRNS

SaaS$161.1M93%
Term license subscriptions$6.9M4%
Maintenance and services$5.2M3%

Related Comparisons